scholarly article | Q13442814 |
P356 | DOI | 10.3174/AJNR.A4436 |
P698 | PubMed publication ID | 26316568 |
P50 | author | Vincent Deramecourt | Q51346936 |
Olivier Outteryck | Q64095683 | ||
P2093 | author name string | P Vermersch | |
A Lacour | |||
J Hodel | |||
X Leclerc | |||
J-P Pruvo | |||
S Verclytte | |||
P2860 | cites work | Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. | Q30583907 |
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy | Q30689194 | ||
Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging | Q30820686 | ||
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients | Q34562841 | ||
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases | Q37714089 | ||
MRI pattern in asymptomatic natalizumab-associated PML. | Q41745436 | ||
Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? | Q43897444 | ||
JC virus infection of the brain | Q45377474 | ||
P433 | issue | 12 | |
P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
P304 | page(s) | 2296-2302 | |
P577 | publication date | 2015-08-27 | |
P1433 | published in | American Journal of Neuroradiology | Q15762571 |
P1476 | title | Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. | |
P478 | volume | 36 |
Q33810020 | Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study |
Q36352813 | Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression. |
Q40039520 | Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies |
Q48094258 | Low Signals on T2* and SWI Sequences in Patients with MS with Progressive Multifocal Leukoencephalopathy. |
Q40168148 | Low-signal Intensity Rims along the Cerebral Cortex and U-fibers on Susceptibility-weighted Imaging in Progressive Multifocal Leukoencephalopathy. |
Q47433677 | Pathologic Correlation of Paramagnetic White Matter Lesions in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia |
Q30245002 | Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals. |
Q52718488 | Progressive multifocal leukoencephalopathy after fingolimod treatment. |
Q58007550 | REPLY: |
Q38659676 | Susceptibility-Based Neuroimaging: Standard Methods, Clinical Applications, and Future Directions |
Q90288758 | Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration |
Search more.